During the past decade, Advancing Vision Research conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advancing Vision Research" #1 sponsor was "Aerie Pharmaceuticals" with 3 trials, followed by "Aerpio Therapeutics" with 1 trials sponsored, "Allergan" with 1 trials sponsored, "Andover Eye Associates" with 1 trials sponsored and "HanAll BioPharma Co., Ltd." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advancing Vision Research" #1 collaborator was "Daewoong Pharmaceutical Co. LTD." with 1 trials as a collaborator, "Regeneron Pharmaceuticals" with 1 trials as a collaborator and "Statistics & Data Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Advancing Vision Research" are "Dry Eye" (2 trials), "Ocular Hypertension" (2 trials), "Atopic Keratoconjunctivitis" (1 trials), "Dry Eye Disease" (1 trials) and "Dry Eye Disease (DED)" (1 trials). Many other conditions were trialed in "Advancing Vision Research" in a lesser frequency.

Most popular intervention types in "Advancing Vision Research" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "0.25% HL036 Ophthalmic Solution" (1 trials), "011516X (New Artificial Tear Formulation)" (1 trials), "AKB-9778" (1 trials) and "AR 15512 Ophthalmic Solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advancing Vision Research" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Advancing Vision Research". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Advancing Vision Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Advancing Vision Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".